HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thymosin beta10 inhibits cell migration and capillary-like tube formation of human coronary artery endothelial cells.

Abstract
Thymosin beta10 is a cytoplasm G-actin sequestering protein whose functions are largely unknown. To determine the direct effects of exogenous thymosin beta10 on angiogenic potentials as endothelial cell migration and capillary-like tube formation, human coronary artery endothelial cells (HCAECs) were incubated with increasing doses of thymosin beta10 (25-100 ng/ml). By using a modified Boyden chamber assay, thymosin beta10 inhibited cell migration in a dose- and time-dependent manner with the maximal effect being a 36% reduction at 100 ng/ml as compared to controls (P < 0.01). In addition, thymosin beta10 (100 ng/ml) significantly inhibited the capillary-like tube-formation of HCAECs on Matrigel, showing a 21% reduction of the total tube length as compared to negative controls (P < 0.01). Furthermore, by using real time PCR analysis, thymosin beta10 significantly decreased mRNA levels of vascular endothelial growth factor (VEGF), VEGF receptor-1 (VEGFR-1) and integrin alphaV after 24 h treatment in HCAECs. By contrast, thymosin beta4 significantly increased HCAEC migration. These results indicate that thymosin beta10, but not thymosin beta4, have direct inhibitive effects on endothelial migration and tube formation that might be mediated via downregulation of VEGF, VEGFR-1 and integrin alphaV in HCAECs. This study suggests a potential therapeutic application of thymosin beta10 to the diseases with excessive angiogenesis such as cancer.
AuthorsHong Mu, Ryuji Ohashi, Hui Yang, Xinwen Wang, Min Li, Peter Lin, Qizhi Yao, Changyi Chen
JournalCell motility and the cytoskeleton (Cell Motil Cytoskeleton) Vol. 63 Issue 4 Pg. 222-30 (Apr 2006) ISSN: 0886-1544 [Print] United States
PMID16496302 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright 2006 Wiley-Liss, Inc.
Chemical References
  • Integrin alpha Chains
  • Vascular Endothelial Growth Factor A
  • thymosin beta(4)
  • Thymosin
  • thymosin beta(10)
  • Vascular Endothelial Growth Factor Receptor-1
Topics
  • Capillaries (drug effects)
  • Cell Line
  • Cell Movement (drug effects)
  • Coronary Vessels (drug effects, physiology)
  • Endothelium, Vascular (cytology, drug effects)
  • Humans
  • Integrin alpha Chains (metabolism)
  • Models, Biological
  • Neovascularization, Physiologic (drug effects)
  • Thymosin (pharmacology)
  • Vascular Endothelial Growth Factor A (metabolism)
  • Vascular Endothelial Growth Factor Receptor-1 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: